Trials / Unknown
UnknownNCT04902586
Effect of Radiotherapy Concurrent of TTFields in Patients With Glioblastoma
The Clinical Effect and Safety of Radiotherapy Concurrent of TTFields in the Treatment of Post-operation Patients With Glioblastoma.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Zhongnan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
TTFields has been approved by the FDA for the treatment of patients with glioblastoma multiforme. However, the clinical effect and safety of radiotherapy concurrent of TTFields is not definite. In this study, the investigators conduct a phase II clinical trial to evaluate the efficacy and safety of this strategy.
Detailed description
the investigators plan to recruit 30 patients to evaluate the efficacy and safety of this strategy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TTFields | The TTFields, consisting of low-intensity, 200 kHz frequency, alternating electric fields, was delivered (≥ 18 hours/d) via 4 transducer arrays on the shaved scalp and connected to a portable device. |
Timeline
- Start date
- 2021-06-19
- Primary completion
- 2021-12-19
- Completion
- 2022-07-19
- First posted
- 2021-05-26
- Last updated
- 2021-05-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04902586. Inclusion in this directory is not an endorsement.